278 related articles for article (PubMed ID: 21088258)
1. Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity.
Zhao D; Alizadeh D; Zhang L; Liu W; Farrukh O; Manuel E; Diamond DJ; Badie B
Clin Cancer Res; 2011 Feb; 17(4):771-82. PubMed ID: 21088258
[TBL] [Abstract][Full Text] [Related]
2. Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy.
Alizadeh D; Zhang L; Brown CE; Farrukh O; Jensen MC; Badie B
Clin Cancer Res; 2010 Jul; 16(13):3399-408. PubMed ID: 20570924
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in mice.
Fan H; Zhang I; Chen X; Zhang L; Wang H; Da Fonseca A; Manuel ER; Diamond DJ; Raubitschek A; Badie B
Clin Cancer Res; 2012 Oct; 18(20):5628-38. PubMed ID: 22904105
[TBL] [Abstract][Full Text] [Related]
4. TLR ligands in the local treatment of established intracerebral murine gliomas.
Grauer OM; Molling JW; Bennink E; Toonen LW; Sutmuller RP; Nierkens S; Adema GJ
J Immunol; 2008 Nov; 181(10):6720-9. PubMed ID: 18981089
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.
El Andaloussi A; Sonabend AM; Han Y; Lesniak MS
Glia; 2006 Nov; 54(6):526-35. PubMed ID: 16906541
[TBL] [Abstract][Full Text] [Related]
6. CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model.
Jordan M; Waxman DJ
Cancer Lett; 2016 Apr; 373(1):88-96. PubMed ID: 26655275
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs.
Carpentier AF; Xie J; Mokhtari K; Delattre JY
Clin Cancer Res; 2000 Jun; 6(6):2469-73. PubMed ID: 10873101
[TBL] [Abstract][Full Text] [Related]
8. Immunostimulatory CpG on Carbon Nanotubes Selectively Inhibits Migration of Brain Tumor Cells.
Alizadeh D; White EE; Sanchez TC; Liu S; Zhang L; Badie B; Berlin JM
Bioconjug Chem; 2018 May; 29(5):1659-1668. PubMed ID: 29526082
[TBL] [Abstract][Full Text] [Related]
9. Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model.
VanHandel M; Alizadeh D; Zhang L; Kateb B; Bronikowski M; Manohara H; Badie B
J Neuroimmunol; 2009 Mar; 208(1-2):3-9. PubMed ID: 19181390
[TBL] [Abstract][Full Text] [Related]
10. Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model.
Ouyang M; White EE; Ren H; Guo Q; Zhang I; Gao H; Yanyan S; Chen X; Weng Y; Da Fonseca A; Shah S; Manuel ER; Zhang L; Vonderfecht SL; Alizadeh D; Berlin JM; Badie B
PLoS One; 2016; 11(2):e0148139. PubMed ID: 26829221
[TBL] [Abstract][Full Text] [Related]
11. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
Roda JM; Parihar R; Carson WE
J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic approach with oligodeoxynucleotides containing CpG motifs (CpG-ODN) in malignant glioma.
Ursu R; Carpentier AF
Adv Exp Med Biol; 2012; 746():95-108. PubMed ID: 22639162
[TBL] [Abstract][Full Text] [Related]
13. S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages.
Wang H; Zhang L; Zhang IY; Chen X; Da Fonseca A; Wu S; Ren H; Badie S; Sadeghi S; Ouyang M; Warden CD; Badie B
Clin Cancer Res; 2013 Jul; 19(14):3764-75. PubMed ID: 23719262
[TBL] [Abstract][Full Text] [Related]
14. Implication of macrophages in tumor rejection induced by CpG-oligodeoxynucleotides without antigen.
Auf G; Carpentier AF; Chen L; Le Clanche C; Delattre JY
Clin Cancer Res; 2001 Nov; 7(11):3540-3. PubMed ID: 11705874
[TBL] [Abstract][Full Text] [Related]
15. Treg depletion followed by intracerebral CpG-ODN injection induce brain tumor rejection.
Jarry U; Donnou S; Vincent M; Jeannin P; Pineau L; Fremaux I; Delneste Y; Couez D
J Neuroimmunol; 2014 Feb; 267(1-2):35-42. PubMed ID: 24369298
[TBL] [Abstract][Full Text] [Related]
16. Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model.
Ginzkey C; Eicker SO; Marget M; Krause J; Brecht S; Westphal M; Hugo HH; Mehdorn HM; Steinmann J; Hamel W
Cancer Immunol Immunother; 2010 Apr; 59(4):541-51. PubMed ID: 19798500
[TBL] [Abstract][Full Text] [Related]
17. Intratumorally CpG immunotherapy with carbon nanotubes inhibits local tumor growth and liver metastasis by suppressing the epithelial-mesenchymal transition of colon cancer cells.
Jin H; Gao S; Song D; Liu Y; Chen X
Anticancer Drugs; 2021 Mar; 32(3):278-285. PubMed ID: 32976213
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment.
Ben Abdelwahed R; Cosette J; Donnou S; Crozet L; Ouakrim H; Fridman WH; Sautès-Fridman C; Mahjoub A; Fisson S
J Exp Clin Cancer Res; 2013 Apr; 32(1):18. PubMed ID: 23561041
[TBL] [Abstract][Full Text] [Related]
20. An effective dendritic cell-based vaccine containing glioma stem-like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma.
Zhu S; Lv X; Zhang X; Li T; Zang G; Yang N; Wang X; Wu J; Chen W; Liu YJ; Chen J
Int J Cancer; 2019 Jun; 144(11):2867-2879. PubMed ID: 30565657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
